A detailed history of Kb Financial Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Kb Financial Partners, LLC holds 7,684 shares of AZN stock, worth $539,801. This represents 0.15% of its overall portfolio holdings.

Number of Shares
7,684
Previous 7,682 0.03%
Holding current value
$539,801
Previous $550,000 5.45%
% of portfolio
0.15%
Previous 0.15%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$64.85 - $71.7 $129 - $143
2 Added 0.03%
7,684 $520,000
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $487,412 - $528,547
6,972 Added 981.97%
7,682 $550,000
Q1 2023

May 16, 2023

SELL
$63.15 - $71.6 $21,281 - $24,129
-337 Reduced 32.19%
710 $49,000
Q4 2022

Feb 17, 2023

BUY
$54.21 - $70.44 $7,860 - $10,213
145 Added 16.08%
1,047 $71,000
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $46,286 - $118,509
873 Added 3010.34%
902 $49,000
Q4 2021

Feb 18, 2022

BUY
$54.02 - $63.83 $1,566 - $1,851
29 New
29 $2,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $218B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Kb Financial Partners, LLC Portfolio

Follow Kb Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kb Financial Partners, LLC with notifications on news.